March 31, 2020

Theratechnologies Provides Business Update Related To Current Covid-19 Situation

Supply chain remains intact with ample inventory of commercial medicines
Research and development activities currently progressing
Company withdraws 2020 financial guidance until further notice

Montreal, Canada – March 31, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today issued an update on the Company’s activities in relation to the current worldwide COVID-19 pandemic.